LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.1
19.69 84.90 1074 1239 0.8665 0.9273
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
21.40 84.90 828 1454 0.5692 0.7431
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
21.40 84.90 910 1454 0.6256 0.7837
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
21.40 84.90 942 1454 0.6476 0.7988
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
21.40 84.90 1104 1454 0.7589 0.8698
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
21.40 84.90 43 1454 0.0296 -0.1529
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
21.40 84.90 1094 1454 0.7521 0.8657
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
23.10 84.90 982 1616 0.6076 0.7788
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
23.10 84.90 1068 1616 0.6608 0.8143
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
23.10 84.90 1009 1616 0.6243 0.7902
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
23.10 84.90 1138 1616 0.7041 0.8416
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
23.10 84.90 59 1616 0.0365 -0.0820
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
23.10 84.90 1158 1616 0.7165 0.8491
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
24.81 84.90 852 1769 0.4815 0.6927
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
24.81 84.90 902 1769 0.5098 0.7149
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
24.81 84.90 923 1769 0.5216 0.7239
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
24.81 84.90 1011 1769 0.5714 0.7601
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
24.81 84.90 63 1769 0.0356 -0.0658
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
24.81 84.90 1116 1769 0.6307 0.8003
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
26.51 84.90 876 1923 0.4555 0.6794
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
26.51 84.90 918 1923 0.4773 0.6970
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
26.51 84.90 982 1923 0.5106 0.7226
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
26.51 84.90 1064 1923 0.5533 0.7536
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
26.51 84.90 66 1923 0.0343 -0.0544
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
26.51 84.90 1188 1923 0.6177 0.7970
MN20160318_Q02
N17